title: Recent progress in the development of Terumo implantable left ventricular assist system.
abstract: The research group of the Terumo Corporation, the NTN Corporation, and Setsunan University (T. Akamatsu) has been developing an implantable left ventricular assist system (ILVAS) featuring a centrifugal blood pump with a magnetically suspended impeller (MSCP). The impeller of the MSCP is suspended by a magnetic bearing, providing contact-free rotation of the impeller inside the pump housing. Thus the MSCP is expected to provide years of long-term durability. Ex vivo chronic sheep experiments using the extracorporeal model (Model I) demonstrated long-term durability, nonthrombogenicity, and a low hemolysis rate (plasma free Hb <6 mg/dl) for more than 2 years. The prototype implantable model (Model II; 196 ml, 400 g) was evaluated ex vivo in 2 sheep and intrathoracically implanted in a small sheep (45 kg). These experiments were terminated at 70, 79, and 17 days, respectively, because of blood leakage through the connector system within the housing of Model II. There was no thrombus formation on the retrieved pump surfaces. A new connector system was introduced to the Model II pump (modified Model II), and the pump was intrathoracically implanted in a sheep. Pump flow rate was maintained at 3-7 L/min at 1700-1800 rpm. The temperature elevation on the surfaces of the motor and the electromagnet inside the pump casing was kept less than 6 degrees C. The temperature of the tissue adjacent to the pump casing became normal 10 days postoperatively. The sheep survived for more than 5 months without any sign of mechanical failure or thromboembolic complication. In vitro real-time endurance tests of motor bearings made of stainless steel and silicone nitride have been conducted for more than 1 year without any sign of bearing wear. The next prototype system (Model III), with an implantable controller and a new MSCP with reduced input power, has been developed with a view toward a totally implantable LVAS.
authors.affiliation: Terumo Corporation, R&D Center, Kanagawa, Japan.
authors.forename: C
authors.initials: C
authors.lastname: Nojiri
authors.forename: T
authors.initials: T
authors.lastname: Kijima
authors.forename: J
authors.initials: J
authors.lastname: Maekawa
authors.forename: K
authors.initials: K
authors.lastname: Horiuchi
authors.forename: T
authors.initials: T
authors.lastname: Kido
authors.forename: T
authors.initials: T
authors.lastname: Sugiyama
authors.forename: T
authors.initials: T
authors.lastname: Mori
authors.forename: N
authors.initials: N
authors.lastname: Sugiura
authors.forename: T
authors.initials: T
authors.lastname: Asada
authors.forename: H
authors.initials: H
authors.lastname: Shimane
authors.forename: T
authors.initials: T
authors.lastname: Ozaki
authors.forename: M
authors.initials: M
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Akamatsu
authors.forename: T
authors.initials: T
authors.lastname: Akutsu
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D003404:Creatinine / Q000097:blood; D004867:Equipment Design; D006353:Heart-Assist Devices; D006454:Hemoglobins / Q000378:metabolism; D008422:Materials Testing; D008855:Microscopy, Electron, Scanning; D019919:Prosthesis Implantation; D012756:Sheep
chemical_list: D006454:Hemoglobins; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase